← Insider buys
KRTX

Karuna Therapeutics, Inc.

Chief Medical Officer Stephen K. Brannan sold $1.2M of Karuna Therapeutics, Inc.

Sold$1,217,300
$243.46Price
5,000Shares
−25%Stake

What KRTX did after the filing

Prices for KRTX after this filing aren't in yet.

Traded Fri, Sep 9. Filed Mon, Sep 12, 12:25 PM ET, during the session. Not investment advice.